Drug Shortage Report for BRIVLERA
| Report ID | 45634 |
| Drug Identification Number | 02452979 |
| Brand name | BRIVLERA |
| Common or Proper name | BRIVARACETAM |
| Company Name | UCB CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BRIVARACETAM |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 60 TABLETS |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-04-13 |
| Estimated end date | 2018-04-30 |
| Actual end date | 2018-05-04 |
| Shortage status | Resolved |
| Updated date | 2018-05-05 |
| Company comments | ALL OTHER BRIVARACETAM STRENGTHS ARE AVAILABLE (10MG, 25MG, 50MG AND 75MG) |
| Health Canada comments | |
| Contact Address | 2201 BRISTOL CIRCLE OAKVILLE, ONTARIO CANADA L6H 0J8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.